CPSS vs REGN · P/E 11, rev $393.5M vs P/E 14, rev $14.34B
Consumer Portfolio Services Inc (CPSS) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Consumer Portfolio Services Inc (CPSS) is a credit services company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CPSS revenue for 2024-12-31 was $393.5M. Net income was $19.2M. Revenue was up 11.8% from 2023-12-31 to 2024-12-31. CPSS currently screens at market cap $204.6M and trailing P/E 11.1.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CPSS currently screens at market cap $204.6M and trailing P/E 11.1. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CPSS and REGN stock pages for the full models.
Not investment advice.